AI that simply streamlines clinical tasks will not by itself ease hospital capacity pressures; only tools or procurement that change who bears risk or make outcomes more observable can alter entrenched system behaviour, so leaders must pair AI with governance and incentive reform.

Main Finding

AI interventions that only reduce effort or increase observability are likely to improve local performance but not change system‑level outcomes when underlying incentives remain the same. Only AI (or AI‑enabled) interventions that change the mechanism mapping local actions into local consequences—i.e., that reallocate or bound the downside risk of cooperative actions—can plausibly shift which equilibria are stable and thus produce reliable system‑level transformation.

Key Points

• Coordination constraint and incentive structure, not technical task performance alone, often limit healthcare productivity gains from AI.
• Three archetypal AI interventions:
  • Effort‑reducing AI: lowers the direct effort or time cost of actions (e.g., LLM drafting, ambient documentation).
  • Observability‑oriented AI: increases visibility or predictability of system state (e.g., discharge forecasting, congestion alerts).
  • Mechanism‑level AI: changes how local actions map to downstream consequences by bounding or redistributing local risk (requires institutional commitment).
• Stylised result from a capacity‑signalling game (wards choose Expose E or Buffer B):
  • Baseline: buffering is individually rational and (B,...,B) is a Nash equilibrium even if (E,...,E) is socially better.
  • Effort reductions change ci → ci − Δ(ai). Unless Δ(E) ≫ Δ(B), the best‑response ordering stays the same — equilibrium persists.
  • Observability introduces probability p of detection with expected penalty pF for buffering; only if pF outweighs the buffering advantage will behaviour change.
  • Mechanism change κ reduces the local cost of exposure ci(E | κ) so that exposing becomes an individually rational best response; this can make (E,...,E) a Nash equilibrium without ongoing monitoring.
• Practical implication: many current AI tools are of the first two kinds and thus can be absorbed into existing equilibria — delivering local value but little system‑level change.
• Mechanism‑level interventions are institutional and harder to procure/govern; they often require pre‑committed risk‑sharing, staffing commitments, or centralised responsibilities.
• Extensions and caveats: asymmetry between units, veto/threshold games, dynamic/repeated interaction and evolutionary selection all reinforce the core insight — incentives drive equilibrium selection.

Data & Methods

• This is a theoretical, game‑theoretic, and conceptual analysis rather than an empirical study.
• Stylised model used:
  • Agents: N wards, action ai ∈ {E (expose), B (buffer)}.
  • Payoff: ui(ai, a−i) = b(ai, a−i) − ci(ai), where b captures system benefits and ci local costs; assumed ci(E) > ci(B) and b(E, B−i) ≈ b(B, B−i) (unilateral exposure gives little marginal system benefit).
  • Equilibrium analysis: best‑response comparisons and Nash equilibrium identification under modifications.
• How each archetype modifies the baseline game:
  • Effort reduction: ci(ai) → ci(ai) − Δ(ai).
  • Observability: ui(B, a−i) → ui(B, a−i) − p(a−i)F, with p exogenous probability detection leads to consequence F.
  • Mechanism design: introduce κ so ci(E) → ci(E | κ) with ci(E | κ) < ci(E).
• Analysis focuses on whether these changes reverse the inequality ui(B, B−i) > ui(E, B−i) that makes buffering a stable best response.
• Limitations of method:
  • Static Nash framework (deliberately minimal); dynamic/repeated games, strategic alteration of detectability p, heterogeneity across wards, and implementation costs of mechanism changes are discussed but not modelled formally.
  • No empirical calibration or cost estimates for mechanism interventions.

Implications for AI Economics

• Investment and procurement
  • Prioritise deployments whose primary effect is to change incentives (mechanism‑level), or pair technical tools with institutional reforms that reallocate risk. Expect smaller system‑level returns from stand‑alone effort‑reducing or observability tools.
  • Account for the governance and transaction costs of mechanism interventions when evaluating ROI — these may be high but are necessary to unlock systemic gains.
• Evaluation and metrics
  • Standard local metrics (task time saved, clinician satisfaction) will overestimate system impact if incentives are unchanged.
  • Trials and pilots should measure downstream, system‑level outcomes (flow, admissions, congestion) and explicitly capture distributional effects across units.
  • Design RCTs or natural experiments that manipulate incentives/risk sharing (not only the AI tool) to identify causal system effects.
• Policy and regulation
  • Regulators and payers should consider incentives and risk redistribution (e.g., bundled payments, central escalation roles) as complements to AI adoption.
  • Procurement frameworks need to reward solutions that include credible institutional commitments (pre‑committed staffing redeployments, guaranteed central capacity handling) rather than only software features.
• Theory and empirical agenda for AI economics
  • Model heterogeneity in local costs and asymmetric equilibria; quantify the size of local downside risk that must be absorbed to change equilibria.
  • Empirically estimate p (detectability) and F (expected organizational consequence) where observability tools are deployed.
  • Cost‑benefit analyses should compare (a) the costs of mechanism redesign and governance with (b) the social value unlocked by moving to a cooperative equilibrium.
  • Study evolutionary/dynamic adoption: how do incentive changes alter strategy selection over time?
• Distributional consequences and political economy
  • Mechanism changes reallocate risk — policymakers must consider winners/losers and design compensation or contractual arrangements to achieve buy‑in.
  • Expect greater organisational friction for mechanism interventions; transaction costs and governance burdens affect feasibility and speed of adoption.

Summary: Technical improvements (faster, more visible, or more accurate) are necessary but not sufficient for system‑level transformation — changing the incentives (mechanisms) that make cooperative actions individually rational is the critical and often institutional step for realizing aggregate gains from healthcare AI.